Authors:
Forsberg, G
Ohlsson, L
Brodin, T
Bjork, P
Lando, PA
Shaw, D
Stern, PL
Dohlsten, M
Citation: G. Forsberg et al., Therapy of human non-small-cell lung carcinoma using antibody targeting ofa modified superantigen, BR J CANC, 85(1), 2001, pp. 129-136
Authors:
Tordsson, J
Lavasani, S
Ohlsson, L
Karlstrom, P
Svedberg, H
Abrahmsen, L
Brodin, T
Citation: J. Tordsson et al., A3 - A novel colon and pancreatic cancer reactive antibody from a primate phage library selected using intact tumour cells, INT J CANC, 87(4), 2000, pp. 559-568
Authors:
Sogaard, M
Ohlsson, L
Kristensson, K
Rosendahl, A
Sjoberg, A
Forsberg, G
Kalland, T
Dohlsten, M
Citation: M. Sogaard et al., Treatment with tumor-reactive Fab-IL-2 and Fab-Staphylococcal enterotoxin A fusion proteins leads to sustained T cell activation, and long-term survival of mice with established tumors, INT J ONCOL, 15(5), 1999, pp. 873-882
Authors:
Meineche-Schmidt, V
Talley, NJ
Pap, A
Kordecki, H
Schmid, V
Ohlsson, L
Wahlqvist, P
Wiklund, I
Bolling-Sternevald, E
Citation: V. Meineche-schmidt et al., Impact of functional dyspepsia on quality of life and health care consumption after cessation of antisecretory treatment - A multicentre 3-month follow-up study, SC J GASTR, 34(6), 1999, pp. 566-574
Authors:
Litton, MJ
Dohlsten, M
Rosendahl, A
Ohlsson, L
Sogaard, M
Andersson, J
Andersson, U
Citation: Mj. Litton et al., The distinct role of CD4(+) and CD8(+) T-cells during the anti-tumour effects of targeted superantigens, BR J CANC, 81(2), 1999, pp. 359-366